Fans of the Yellowstone spin-off Marshals have reason to be excited: the upcoming second season is set to address one of the biggest criticisms leveled at its predecessor. While Yellowstone famously used a cancer scare for Kevin Costner's John Dutton as a plot device, Marshals is taking a more meaningful approach with its own character's health crisis.
In a recent interview with Collider, star Logan Marshall-Green, who plays Pete "Cal" Calvin, offered a tantalizing glimpse into what's ahead. The series, which follows Kayce Dutton (Luke Grimes) as he trades his cowboy hat for a U.S. Marshals badge, will delve deep into Cal's battle with the Pancoast tumor he was diagnosed with in the first season's penultimate episode, "The Devil At Home." The diagnosis, which Cal initially kept from his partner Belle (Arielle Kebbel), is set to become a central focus, impacting his relationship with his daughter Maddie (Morgan Lindholm) and his role on the team.
This commitment to exploring Cal's illness is a deliberate departure from how Yellowstone handled John Dutton's health scare. In the original series, John's suspected cancer was used primarily to create urgency in his fight for the ranch, but the storyline was ultimately revealed to be a stomach ulcer, and the emotional weight was largely discarded. Marshall-Green's comments suggest Marshals is determined to avoid that pitfall.
"Cancer is too important a topic to dance around," Marshall-Green told TVLine after the first season finale. "It doesn't matter whether you fought for the country or not, it doesn't matter what you do. This thing is not biased. So I hope Cal is put through the wringer with this, because that's the story that needs to be told."
The actor's passion for the storyline is evident, and he's promised that the second season will not shy away from the difficult realities of the disease. He revealed that the plot is inspired by a real-life story from one of the show's creators, adding a layer of authenticity that could make Cal's journey all the more compelling.
"It's based on a creator's real story," Marshall-Green explained. "So we're going to go after it and we're still in the middle of it. And I couldn't tell you, to be completely honest. Those kinds of things I don't want to know. Just want to live it human."
This approach signals a shift for the Taylor Sheridan universe, which has often been criticized for prioritizing action and plot over character development. By giving Cal a deeply personal and challenging arc, Marshals has the opportunity to distinguish itself as a more character-driven entry in the franchise. The show's first season was a streaming hit, but it lost some momentum by its end. This deeper exploration of Cal's personal struggles could be just what the series needs to regain its footing.
As Marshals continues to carve out its own identity, it's clear that the creative team is listening to feedback and willing to take risks. The decision to fully embrace Cal's cancer storyline is a bold one, and it could pay off in a big way. For fans of Sheridan's streaming empire, this is a promising sign that Marshals is ready to step out of Yellowstone's shadow and tell its own powerful story.
With other Sheridan projects dominating the charts, Marshals has big shoes to fill. But by tackling a subject as universal and impactful as cancer with the seriousness it deserves, the show is setting itself up for a season that could resonate deeply with audiences. The wait for Season 2 may be tough, but the promise of a more nuanced and emotionally rich narrative is certainly worth it.
